瘤微环境响应纳米药物用于栓塞治疗和增强化疗
Jialiang Zheng1,2, Zhenhang Lin1, Xi Li3
1Cancer Research Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China.
ACS applied materials & interfaces
|February 27, 2025
概括
这项研究引入了一种用于向癌症栓塞和药物输送的新型纳米药物. 它通过阻断血液供应和激活低氧敏感药物来安全有效地治疗瘤,克服传统疗法的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 栓塞疗法是一种诱导瘤缺氧的抗瘤方法,但需要高度专业知识并带有风险.
- 传统的缺氧激活前期药物治疗可能会导致缺氧不足.
研究的目的:
- 开发一种安全有效的栓塞策略,使用一种新的纳米药物输送平台.
- 将向栓塞与低氧激活的前期药物治疗结合起来,以增强抗瘤效果.
主要方法:
- 一个基于多多多巴胺的 (MPDA) 药物输送平台是用融合蛋白来设计的.
- 融合蛋白准了HER-2,MMP-2,并通过tTF调解了栓塞.
- 该平台上充满了提拉帕扎明 (TPZ),这是一个低氧激活的前药.
主要成果:
- 这种纳米药物专门针对HER-2并使瘤血管栓塞.
- 在酸性瘤微环境 (TME) 条件下,MPDA释放TPZ.
- 栓塞诱导的缺氧增强TPZ激活,导致瘤细胞死亡.
结论:
- 这种工程纳米药物提供了一个安全有效的栓塞策略.
- 它克服了传统栓塞治疗的局限性,并增强了缺氧激活的前期药物治疗.
- 该平台显示了改善癌症治疗的前景,通过结合向药物和触发药物激活来改善癌症治疗.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461


